Text Size
48 studies found for:    Carcinoembryonic antigen

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Immune Response in Peripheral Blood of Patients With Colon Cancer
Condition: Colorectal Cancer
Interventions: Other: immunoenzyme technique;   Other: laboratory biomarker analysis
22 Recruiting L-BLP25 (Stimuvax) in Rectal Cancer
Condition: Rectal Cancer
Interventions: Other: Chemoradiation Therapy;   Drug: Cyclophosphamide;   Biological: L-BLP25
23 Unknown † Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: floxuridine;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
24 Recruiting Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Other: Blood sampling
25 Active, not recruiting
Has Results 		A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: ZD6474 (vandetanib)
26 Recruiting PET-CT and Circulating Tumor Cells in Colorectal Cancer
Conditions: Colorectal Cancer;   Metastasis
Intervention: Drug: Chemotherapy
27 Active, not recruiting
Has Results 		An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: ZD6474 (Vandetanib)
28 Recruiting Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer
Condition: Rectal Cancer
Interventions: Radiation: radiation therapy;   Drug: capecitabine (625mg/m2,bid,d1-5 qw)and oxaliplatin (85mg/m2 d1 qw)
29 Completed Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
Conditions: Breast Cancer;   Colorectal Cancer;   Lung Cancer;   Pancreatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: denileukin diftitox;   Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine;   Biological: therapeutic autologous dendritic cells
30 Completed Enzastaurin for Patients With Metastatic Colorectal Cancer
Condition: Colonic Neoplasms
Intervention: Drug: Enzastaurin HCl
31 Completed Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Biological: MelCancerVac
32 Completed Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Other: laboratory biomarker analysis;   Procedure: cryosurgery;   Procedure: radiofrequency ablation;   Procedure: therapeutic conventional surgery
33 Active, not recruiting Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Conditions: Multiple Endocrine Neoplasia;   Recurrent Thyroid Cancer;   Thyroid Gland Medullary Carcinoma
Interventions: Drug: sorafenib tosylate;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Other: immunohistochemistry staining method;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study
34 Recruiting A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer
Condition: Medullary Thyroid Cancer
Intervention: Biological: GI-6207
35 Completed Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver
Conditions: Colorectal Cancer;   Liver Neoplasms
Intervention: Drug: NV1020
36 Active, not recruiting Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Procedure: CT-scan, CEA, X-ray of lungs
37 Terminated For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy
Conditions: Neoplasm Metastasis;   Colorectal Neoplasms
Interventions: Drug: Celecoxib;   Drug: Irinotecan;   Drug: 5-fluorouracil;   Drug: Leucovorin
38 Recruiting TF2- Small Cell Lung Cancer Radio Immunotherapy
Condition: Small Cell Lung Cancer
Interventions: Drug: Antibody TF2;   Radiation: IMP-288-Lutetium;   Radiation: IMP-288-Indium
39 Active, not recruiting Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Conditions: Recurrent Colon Cancer;   Recurrent Rectal Cancer;   Stage IV Colon Cancer;   Stage IV Rectal Cancer
Interventions: Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: fluorouracil;   Biological: bevacizumab;   Radiation: yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A;   Other: laboratory biomarker analysis
40 Completed An Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Drug: 111In-CS-1008, CS-1008
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-48) Show next page of results
† Indicates status has not been verified in more than two years